Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

acute oral LD50 is > 2000 mg/kg bw

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records
Reference
Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1985
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions
Guideline:
other: EG-Richtlinie 84/449
Version / remarks:
Amtsblatt der Europäischen Gemeinschaften 27, 1984, L251, 96
GLP compliance:
not specified
Test type:
standard acute method
Limit test:
no
Specific details on test material used for the study:
Name of test substance in the report: Neodym-Versatat
Appearance: solid
Molecular weight: 657 g/mole
Molecular formula: C30H57NdO6
Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Winkelmann, Borchen, Germany
- Age at study initiation: about 9 weeks (males) to 14 weeks (females)
- Weight at study initiation: mean 171 g (males) and 176 g (females)
- Fasting period before study: 16 hours
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2 °C
- Humidity (%): 60% +/- 10%
- Photoperiod (hrs dark / hrs light): 12 hours

IN-LIFE DATES: From: 13.08.1985 To: 02.09.1985
Route of administration:
oral: gavage
Vehicle:
DMSO
Details on oral exposure:
VEHICLE
- Amount of vehicle (if gavage): 10/20 mL
Doses:
1000 mg/kg bw and 2000 mg/kg bw
No. of animals per sex per dose:
5/sex/dose
Control animals:
no
Details on study design:
higher doses were not applicable due to the limited solublilty of the test item in the vehicle
Observations:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: twice daily for clinical signs; body weighing before treatment, one week and two weeks after treatment
- Necropsy of survivors performed: yes
Sex:
male
Dose descriptor:
LD50 cut-off
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
males: on male died on day 8 after application of 1000 mg/kg bw; two males died within the first 2 days after application of 2000 mg/kg bw
females: no mortality
Clinical signs:
other: males: both doses led to a reduced general condition and piloerection females: 1000 mg/kg bw were well tolerated; 2000 mg/kg bw led to a reduded general condition
Gross pathology:
in the unscheduled deaths effects slight reddening was seen to the mucous membrane of the stomach and intestine
Executive summary:

In an acute oral toxicity study performed in 1985 the test item was given by oral gavage to 5 Wistar rats/sex in doses of 1000 and 2000 mg/kg bw. As vehicle DMSO was used that was applied in amounts of 10 and 20 mL/kg bw, respectively. Mortality was observed only in males at 1000 (1 male) and 2000 mg/kg bw (2 males). A reduced general condition was seen in all treated males and in females of the 2000 mg/kg bw group. The LD50 was determined in this study with >2000 mg/kg bw.

Endpoint conclusion
Endpoint conclusion:
adverse effect observed
Dose descriptor:
LD50

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

In an acute oral toxicity study performed in 1985 the test item was given by oral gavage to 5 Wistar rats/sex in doses of 1000 and 2000 mg/kg bw. As vehicle DMSO was used that was applied in amounts of 10 and 20 mL/kg bw, respectively. Mortality was observed only in males at 1000 (1 male) and 2000 mg/kg bw (2 males). A reduced general condition was seen in all treated males and in females of the 2000 mg/kg bw group. The LD50 was determined in this study with >2000 mg/kg bw.

Justification for classification or non-classification

Based on the available studies no classification is warranted for acute oral toxicity. No studies are available for acute dermal and acute inhalation toxicity.